Related Experiment Video
Updated: May 22, 2026

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
[Hungarian data on inflammatory bowel diseases: analytical data on ulcerative colistis]
Pál Miheller1, Ferenc Nagy, Károly Palatka
1Semmelweis Egyetem, Általános Orvostudományi Kar II. Belgyógyászati Klinika, Budapest. mihpal@yahoo.co.uk
Establishing a comprehensive inflammatory bowel disease registry in Hungary is crucial for tracking patient data and improving evidence-based medicine. This registry aims to provide a clearer picture of Hungarian therapeutic practices and patient outcomes.
Area of Science:
- Gastroenterology
- Clinical Research
- Health Informatics
Context:
- Prospective data collection is vital for evidence-based medicine, especially with new therapeutic options.
- Hungary has established an Inflammatory Bowel Disease (IBD) registry for prospective patient data collection.
- Standardized data collection and testing needs have increased significantly.
Purpose:
- To present the basic characteristics of a database for patients with ulcerative colitis.
- To outline the methodology of the IBD registry using Microsoft Access and a central server.
- To highlight the importance of a national registry for understanding Hungarian therapeutic practices.
Summary:
- The incidence of inflammatory bowel diseases is increasing in Hungary, though prevalence remains low compared to Europe.
- The registry utilizes Microsoft Access for data management, stored on a central server.
- Frequent use of immunosuppressive medications can complicate the estimation of disease activity.
Impact:
- A national IBD database can provide a complete overview of Hungarian therapeutic practices.
- Prospective data collection from all national centers is highly beneficial.
- Understanding how medications affect laboratory findings is essential for accurate disease severity assessment.
More Related Videos
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
07:38Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
Published on: September 13, 2016
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...